Co-op Board Faces Off Against Shareholders in Controversial Election Battle Over Alleged Conflicts of Interest

In New York, four shareholders in a local cooperative are escalating a dispute over their exclusion from the upcoming board of directors election. Each of these candidates meets the by-law requirement of being both a shareholder and a resident, yet they have been denied placement on the ballot due to alleged conflicts of interest linked to their ties with a social and charitable organization occupying part of the cooperative’s property. The board of the cooperative has expressed concerns, asserting that allowing the petitioners on the ballot could jeopardize the community’s “welfare, financial stability, and governance … Read more

Important Lawsuit Alert: Alto Neuroscience Shareholders Urged to Act by Deadline on Claims Exceeding $100,000

In New York, investors who acquired shares of Alto Neuroscience, Inc. (NYSE: ANRO) worth more than $100,000 between February and October 2024 may want to pay close attention to a developing legal situation. These shareholders are encouraged to reach out to the Shareholders Foundation to explore their potential options regarding a lawsuit centered around their investments. There are rising concerns among investors regarding the trading practices and disclosure policies at Alto Neuroscience, a biotech company engaged in the development of treatments for neurological disorders. The claims stem from allegations that the company may have provided … Read more

Former Louisiana AG Warns Red Cat Shareholders: Key Deadline Approaches for Class Action Lawsuit with Significant Losses

NEW ORLEANS — A recent alert from Kahn Swick & Foti, LLC, a law firm formerly led by Louisiana’s attorney general, is drawing attention to a class-action lawsuit against Red Cat Holdings. Investors who have incurred losses exceeding $100,000 in the company’s shares are being reminded that the deadline for appointing a lead plaintiff is fast approaching. The firm is urging eligible shareholders to consider their options as the deadline for filing claims in the legal action looms. This lawsuit stems from accusations that Red Cat Holdings misrepresented its financial health, leading to significant financial … Read more

Legal Challenge Looms: SINOVAC Board Warns Shareholders of Potential Roadblock to $55 Special Dividend

Sinovac, a leading biopharmaceutical company based in Beijing, is warning its shareholders of a new lawsuit that poses a significant threat to a proposed special dividend of $55.00 per share. This alert comes as Advantech/Prime Success, a party involved in ongoing legal matters with Sinovac, has filed a complaint that could complicate the distribution of the dividend intended for all eligible shareholders. The lawsuit potentially blocks the payment, raising concerns among investors who were eagerly anticipating the dividend. Affected shareholders may be left in uncertainty as they await further developments regarding the case. Sinovac has … Read more